Search
    Skip to main content
    Advertisement

    "CAR-T"

    Search all headlines
    In the last 6 hours
    Legend Biotech (LEGN) Is Up 6.1% After Early In Vivo CAR-T Data for LB2501 – What's Changed Simply Wall St19:26 12-June-26
    In the last 7 days
    T-CURX Non-Viral Siglec-6 Lead CAR-T Program, TCX-001, Was Approved for First-In-Human Phase 1 Clinical Trial in… Biotech, B3C newswire18:07 11-June-26
    Cartesian Therapeutics Shares Jump 24% On Strategic car-T Licensing Agreement RTT News01:25 10-June-26
    OriCell's GPC3 car-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line… PR Newswire (Press Release)10:14 8-June-26
    Car-T therapy brings hope to kidney patients with few transplant options Rock Hill Herald02:06 6-June-26
    In the last month
    Early Complete Response Following CAR-T Therapy Predicts Sustained Remission in LBCL Hematology Advisor23:36 5-June-26
    Non-gene-edited, CD19-targeted, allogeneic car-T cell therapy for relapsed or refractory B-cell acute lymphoblastic… Nature.com11:15 4-June-26
    New clinical trial finds car-T therapy could also help treat kidney failure CBS Philadelphia07:48 4-June-26
    ‘Transformative’ car-T therapy allows three people to receive kidney transplants Nature.com07:03 4-June-26
    CAR-T cell therapy shows promise for treating rheumatoid arthritis News-Medical.Net04:11 4-June-26
    Evolving landscape of targeted immunotherapeutic interventions and car-T therapy for acute myeloid leukemia Nature.com03:13 4-June-26
    With Cencora pact, Gilead looks to grow CAR-T treatment center network FiercePharma01:17 4-June-26
    Bispecific Antibodies Associated With Lower Early Immune-Mediated Toxicity Compared With CAR-T Therapy in DLBCL, FL Hematology Advisor03:20 3-June-26
    ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma Pharmaceutical Technology02:13 3-June-26
    Legend Biotech Shares Surge 20% on Promising ASCO Data for Solid Tumor CAR-T Therapy International Business Times - AU Edition00:11 3-June-26
    AvenCell Therapeutics to Report Phase 1a Results of First-in-Class Switchable Allogeneic CD123… PR Newswire (Press Release)23:32 2-June-26
    T-CURX acquires Pantherna Therapeutics to fast-track non-viral in vivo CAR-T pipeline Manufacturing Chemist00:45 2-June-26
    ASCO: Gilead Presents Early Data For GBM CAR-T Scrip Pharma Intelligence22:18 1-June-26
    T-CURX Acquires Pantherna Therapeutics to Accelerate Clinical Translation of its Non-Viral In Vivo CAR-T Strategies Biotech, B3C newswire17:03 1-June-26
    ASCO 2026 | Oricell's GPC3 car-T Ori-C101 Hits 66.7% Orr in Late-Line HCC, Signaling… PR Newswire (Press Release)12:42 1-June-26
    Kelonia Therapeutics Presents Updated First-in-Human Data from Phase 1 inMMyCAR Study of… Business Wire (Press Release)22:05 31-May-26
    Cardiotoxicity induced by multiple myeloma therapies: mechanistic convergence across proteasome inhibitors, car-T, and… Nature.com01:07 30-May-26
    Imugene targets blood cancer with off-the-shelf CAR-T - ICYMI Proactive Investors (Australia)11:08 29-May-26
    Curocell to retry CAR-T Rimqarto reimbursement in July after first HIRA setback Korea Biomedical Review11:29 28-May-26
    Tata-backed MedTherapy claims car-T breakthrough with one-day production The Economic Times01:07 28-May-26
    MedTherapy bets on low-cost car-T manufacturing with Noida Cdmo push The Business Standard23:29 27-May-26
    Understanding the potential of CAR-T therapy in autoimmune disease treatment The Hindu12:31 27-May-26
    King's College London spins out Korecyte Bio Ltd with investment and support from Cell and Gene Therapy Catapult to… King's College London19:52 26-May-26
    De Pakistán a Shanghái: Un viaje de terapia car-T para combatir el linfoma recidivante PR Newswire (Press Release)18:36 26-May-26
    From Pakistan to Shanghai: A car-T Journey Fighting Relapsed Lymphoma PR Newswire (Press Release)10:42 25-May-26
    Cytokine-armored CAR-T cell therapy successfully attacks aggressive brain tumors in mice News-Medical.Net06:03 21-May-26
    Longer-Term Outlook Needed for CAR-T Therapy in Hematologic Cancers Hematology Advisor00:39 21-May-26
    Cytokine-Armored CAR-T Cell Therapy Helps Eliminate Aggressive Brain Tumors in Preclinical Study Newswise (Press Release)00:04 21-May-26
    Precision calcium signaling control may improve future CAR-T therapies News-Medical.Net14:53 19-May-26
    Recognising and managing IEC-HS: A life-threatening complication of CAR-T therapy ecancer01:20 19-May-26
    CAR-T therapy for stiff person syndrome nears approval Labiotech22:16 15-May-26
    STAT Plus: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million STAT21:02 14-May-26
    Govt signs agreement to develop new car-T therapy for Multiple Myeloma AniNews.in18:34 14-May-26
    Curocell bets on faster access as Korea’s 1st homegrown CAR-T enters market Korea Biomedical Review16:00 14-May-26
    With Profitability In Sight, Legend Turns To New CAR-T Frontiers Scrip Pharma Intelligence07:14 14-May-26
    Dr Reddy’s Drops CAR-T, Eyes GLP-1 Upside Scrip Pharma Intelligence22:46 13-May-26
    Curocell aims to become global CAR-T leader with Rimcato Asia Today21:48 13-May-26
    HLB spotlights solid tumor CAR-T platform ahead of FDA cancer decisions Korea Biomedical Review11:23 13-May-26
    SF CAR-T Trial Lets Two HIV Patients Pause Daily Meds, Stuns Researchers Hoodline08:35 13-May-26
    Caring Cross Announces Promising Clinical Data with Single-Dose anti-HIV car-T Cell Therapy PR Newswire (Press Release)02:02 13-May-26
    view more headlines
    12 June 19:26
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.